EVALUATION OF THE USE OF MULTIVITAMIN FOR ACUTE RESPIRATORY INFECTIONS AT BUMI MEDIKA GANESHA HEALTH CENTER ITB

• Main Author: Purnamasari, Rita
• Format: Final Project
• Language: Indonesia
• Online Access: https://digilib.itb.ac.id/gdl/view/45559
• Institution: Institut Teknologi Bandung

Background and purpose: The pharmaceutical industry has grown rapidly both in the world and in Indonesia. One of the growing pharmaceutical products is multivitamin. Multivitamins are a combination of many different vitamins that are normally found in foods and other natural sources, multivitamins are used to provide vitamins that are not taken in through the diet. Multivitamins are used freely in society and the level of multivitamin prescription by doctors is high enough for some diseases, including for Acute Respiratory Infection (ARI). Based on prevalence rates in Bandung, Acute Respiratory Infection (ARI) is the most prevalent disease in 2012 with the percentage of 14.24%. This study aimed to determine patterns of multivitamin prescription, and the usage patterns of multivitamins from the doctor. The study further aimed to determine the effectiveness of multivitamin use in the treatment of Acute Respiratory Infection (ARI) in terms of reduction in the severity and duration of diseases, determine the relationship between lifestyle modification and reduction in disease severity, and determine treatment options that provide the lowest cost among patients who used multivitamins and who did not. Methods: This research was an observational study with evaluative descriptive design carried out retrospectively and concurrently at Bumi Medika Ganesha Health Center ITB from January until May 2015. Results: In the preliminary study, it was shown that multivitamin used in ARI reached 64%. The multivitamin, used were A, B, C, D, E, F brands to be used on average for 10 days. Concurrent study conducted by interviewing 77 patients who did not receive multivitamins from doctors, found 51 patients (66%) used medicines correctly and did not use other multivitamins. The results of interviews with 56 patients who received multivitamins from doctors, showed that only 39 patients (69.6%) used all medicines and multivitamins correctly. Evaluation of the use of multivitamins made by dividing the subjects into two groups: 39 patients who used multivitamins (working group) and 51 patients who did not use multivitamins (control group). The decrease in the severity and duration of disease were not significantly different between the two groups. The relationship between lifestyle modification and reduction in severity of disease could not be established. Analysis of the cost by using the CMA, showed increased costs in patients using multivitamin, but this increase was not significantly different. Conclusions: The use of multivitamin in the therapy of Acute Respiratory Infection might increase of costs, but could not decrease the severity and duration of disease.